54B Subject Index - Innovation in Intervention: i2 Summit 2007J jacc March 6, 2007

Transcription

1 54B Subject Index - Innovation in Intervention: i2 Summit 2007J jacc March 6, 2007 Subject Index Ablation-catheter Adenosine Adverse Events/cardiovascular care Predictors of Major Vascular Complications in Patients Undergoing Percutaneous Coronary Intervention: Insights From the REPLACE-2 Trial## B Aneurysms Angina pectoris Circulating Pregnancy-Associated Plasma Protein-A Levels and Long-Term Prognosis in Patients With Chronic Stable Angina Pectoris## B Angiocardiography X-Ray Dose-Awareness in the Interventional Laboratory: Interactive Display Improves Safety## B Angiogenesis Angiography Incidence of Late Angiographic Stent Thrombosis of Sirolimus-Eluting Stents## B Radiation Exposure During Flat Detector Fluoroscopy: Recognition of a Unique Hazard to Obese Patients## B Referrals in Acute Coronary Events for Cardiac Catheterization, the RACE CAR Study: What Factors Account for Gender Differences in Cardiac Catheterization Referral Rates?## B The Incidence of Contrast-Induced Nephropathy With Iomeprol Is Similar to the Incidence of Contrast-Induced Nephropathy With Iopamidol## B Angioplasty A Prospective, Randomized Trial of Bivalirudin in Acute Coronary Syndromes: One Year Results From the ACUITY Trial## B Bifurcation Lesion Intervention With Cypher and Endeavor Drug-Eluting Stents: A Comparison## B Bivalirudin and Heparin Plus Glycoprotein Inhibition Results in Similar Mortality and Ischemic Outcomes in Patients Undergoing Percutaneous Coronary Intervention: The DEScover Registry## B Culotte Versus T-Stenting in Bifurcation Lesions: Immediate Clinical and Angiographic Results and Mid-Term Clinical Follow-Up## B Effects of Aspirin Dose on Ischemic Events and Bleeding After Percutaneous Coronary Intervention: Insights From the PCI-CURE Study## B Feasibility and Safety of Drug-Eluting Stent Implantaton in the Treatment of Stenosis of Vertebrobasilar Arteries## B Impact of Multivessel Disease on Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock Treated With Percutaneous Coronary Intervention## B Impact of Renal Insufficiency on Clinical Outcomes Following Drug-Eluting Stent Implantation## B Impact of Techniques to Reduce or Prevent Distal Embolization During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Meta- Analysis of Randomized Clinical Trials## B Percutaneous Circulatory Support During High-Risk Angioplasty Procedures: A Multicenter Experience With Impella Technology## B Predictors of Irreversible Events After Percutaneous Coronary Intervention in Unprotected Left Main Lesions## B Radial Versus Femoral Arterial Access in Emergent Coronary Interventions for Acute Myocardial Infarction With ST- Segment Elevation## B Safety and Efficacy of a New Guidewire for Crossing Chronic Total Occlusions: First in Man Results## B Short- and Long-Term Outcomes After Stent-Assisted Percutaneous Treatment of Saphenous Vein Grafts With Drug-Eluting Stents: Have We Made Any Progress?## B Time Delay to Rescue Percutaneous Coronary Intervention and Clinical Endpoints: Results From the REACT Study## B Treatment of Side Branch Plaque Shift in Coronary Bifurcation Lesions With Balloon Cryoangioplasty## B Trends in Outcomes Following Percutaneous Coronary Intervention for Chronic Total Occlusions: 25-Year Experience From the Mayo Clinic## B What Is the Optimal Definition of Renal Failure After Percutaneous Coronary Intervention? Findings From the Guthrie Percutaneous Coronary Intervention Registry## B What Kind of Polymer Is Better for Bifurcation Stenting?## B Angioscopy Quantitative Analysis of Vulnerable Plaque Color Using LCH Color Space## B Anticoagulants A Prospective, Randomized Trial of Bivalirudin in Acute Coronary Syndromes: One Year Results From the ACUITY Trial## B Bivalirudin and Heparin Plus Glycoprotein Inhibition Results in Similar Mortality and Ischemic Outcomes in Patients Undergoing Percutaneous Coronary Intervention: The DEScover Registry## B Impact of Combination of Glycoprotein IIb/IIIa Inhibition and Bivalirudin on Long-Term Outcomes Following Percutaneous Coronary Intervention in Real-World Clinical Practice## B Outcomes of Bivalirudin in Moderate-and High-Risk Patients With Acute Coronary Syndromes and Renal Insufficiency: An ACUITY Substudy## B Aorta Aortic diseases Experience With the Self-Expanding 21 French Percutaneous CoreValve Aortic Valve Prosthesis in High-Risk and Inoperable Patients With Symptomatic Aortic Valve Stenosis## B Aortic regurgitation Periventricular Nonsurgical Aortic Valve Placement With Subsequent Use of Myocardial Plugs## B

2 JACC March 6, 2007 Innovation in Intervention: i2 Summit Subject Index 55B Aortic valve stenosis Three-Year Clinical and Echocardiographic Follow-Up After Percutaneous Edwards Aortic Valve Implantation for Severe Aortic Stenosis in Compassionate Patients## B Aortocoronary bypass Drug-Eluting Stents in the Treatment of Saphenous Vein Graft Disease: Poor Outcome in Diffusely Diseased Grafts## B Arteries Aspirin Effects of Aspirin Dose on Ischemic Events and Bleeding After Percutaneous Coronary Intervention: Insights From the PCI-CURE Study## B Safety and Efficacy of Desensitization Procedure in Patients With Aspirin Sensitivity Undergoing Percutaneous Coronary Stenting## B Assisted circulation Percutaneous Circulatory Support During High-Risk Angioplasty Procedures: A Multicenter Experience With Impella Technology## B Atherectomy Rotational Atherectomy Prior to the Stenting With Sirolimus- Eluting Stent for Diffuse In-Stent Restenosis: Multicenter Registry in Asia## B The Efficacy of Pre-Drug-Eluting Stent Debulking by Directional Atherectomy for Bifurcated Lesions: A Multicenter Prospective Registry## B Atherosclerosis Morphologic Feature and Frequency of Coronary Pre- Rupture Thin-Cap Fibroatheroma in Patients With Acute Myocardial Infarction and Stable Angina Pectoris: A Three-Vessel Optical Coherence Tomography Study## B Blood cells Calcium Characterization of the Intravascular Ultrasound Radiofrequency Signal Within Regions of Acoustic Shadowing Behind Calcium## B Cardiac surgery Comparison of Mid-Term Results of Left Main Disease Treatment by Risk Stratification Systems## B Cardiac tamponade Coronary Artery Perforations: Incidence, Predictors and Clinical Outcomes: Multicenter Registry in Japan## B Cardiology practice/management One-Year Results of Combined Embolic Protection and Thrombectomy in Percutaneous Coronary Intervention of Acute Myocardial Infarction Using the Proxis - Device## B Quality Improvement: Reducing Door-to-Balloon Times in Patients With ST Elevation Myocardial Infarction: The Penn State HVI Heart Alert Program## B Cardiomyopathies, hypertrophic Clinical and Angiographic Predictors of High-Degree Atrioventricular Block After Percutaneous Septal Myocardial Ablation: Multivariate Analysis of 65 Consecutive Patients## B Cardiovascular disease Two-Year Outcomes in Real-World Experience With Taxus Paclitaxel-Eluting Stent in a Prospective, Multicenter, Consecutively-Enrolling United States Registry: ARRIVE 1## B Carotid stenting Efficacy and Safety of Carotid Artery Stenting in Patients Scheduled for Cardiac Surgery## B Octogenarian Status Is an Independent Risk Factor for Adverse Outcomes After Carotid Stenting## B Safety and Efficacy of Carotid Artery Stenting in Patients With a History of Neck Irradiation## B Cells Central nervous system Feasibility and Safety of Drug-Eluting Stent Implantaton in the Treatment of Stenosis of Vertebrobasilar Arteries## B Clinical trials Contrast media The Effect of Contrast-Induced Nephropathy on Long-Term Renal Function## B The Incidence of Contrast-Induced Nephropathy With Iomeprol Is Similar to the Incidence of Contrast-Induced Nephropathy With Iopamidol## B Coronary artery disease A Prospective Multicenter Randomized Comparison of Paclitaxel Versus Sirolimus-Eluting Stents for Long Coronary Lesion: Six--Month Angiographic Follow-Up Study: Impact of Cilostazol on Neointimal Hyperplasia## B Are Angiographic Restenosis Criteria Functionally Relevant in Evaluation of Jailed Side Branch Lesions at Follow-Up Angiograms?## B Are Drug-Eluting Stents Superior to Bare Metal Stents in Large Coronary Arteries?## B Are Patients With Drug Eluting Stents at Increased Risk for Late Stent Thrombosis? Results From a Nested-Case- Control Study## B Arterial Revascularization Therapies Study Part II - Sirolimus- Eluting Stents for the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions: Three- Year Clinical Outcomes## B Can Rosuvastatin Administration Before Percutaneous Coronary Intervention Reduce the Periprocedural Myocardial Injury in Patients With Stable Angina? Results of a Randomized Study## B Characterization of the Intravascular Ultrasound Radiofrequency Signal Within Regions of Acoustic Shadowing Behind Calcium## B Clinical Results of Percutaneus Coronary Intervention for Chronic Total Occlusion: Predictive Factor for Procedural Failure in Recent Technical Development and New Stiff Guidewire Era## B Coronary Artery Perforations: Incidence, Predictors and Clinical Outcomes: Multicenter Registry in Japan## B Culotte Versus T-Stenting in Bifurcation Lesions: Immediate Clinical and Angiographic Results and Mid-Term Clinical Follow-Up## B First Real-World Experience and 6-Month Clinical Outcome in Patients Treated With a Genous TM Endothelial Progenitor Cell Capturing Stent## B Fractional Flow Reserve-Guided Side Branch Intervention Versus Conventional Intervention in Bifurcation Lesions: Comparison of Long-Term Clinical Outcomes## B Impact of Renal Function on Coronary Plaque Characteristics in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Analysis## B Initial Clinical Experience With Right Ventricular Endocardial Thermography in Transplanted and Coronary Artery Disease Patients.## B Intermediate Volume Operators Attempt Percutaneous Coronary Intervention of Chronic Total Occlusions More Frequently Than Low-or High-Volume Operators: An Analysis From the American College of Cardiology- National Cardiovascular Data Registry Database of 45,826 CTO Patients## B Multiple Thin-Cap Fibroatheromas Assessed by Three-Vessel Histological and Optical Coherence Tomographic Study## B New Technology of Three-Dimensional Coronary Bifurcation Imaging## B New Value of Intraseptal Collateral for Percutaneous Coronary Intervention to Chronic Total Occlusion With Retrograde Approach## B Outcomes of Bivalirudin in Moderate-and High-Risk Patients With Acute Coronary Syndromes and Renal Insufficiency: An ACUITY Substudy## B Physiologic Evaluation of Myocardial Bridging: A New Analysis for an Old Disease## B Relationship Between the 3D Structure of the Left Main Coronary Artery Bifurcation and Double Stenting## B Safety and Efficacy of a New Guidewire for Crossing Chronic Total Occlusions: First in Man Results## B SPIRIT II Study: A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de Novo Native Coronary Artery Lesions## B Three-Year Outcome of Intracoronary Stand-Alone Bolus Administration of Eptifibatide During Coronary Intervention##915-

3 56B Subject Index - Innovation in Intervention: i2 Summit 2007J jacc March 6, 2007 Trends in Outcomes Following Percutaneous Coronary Intervention for Chronic Total Occlusions: 25-Year Experience From the Mayo Clinic## B Coronary circulation Coronary heart disease Coronary microcirculation Impact of Techniques to Reduce or Prevent Distal Embolization During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Meta- Analysis of Randomized Clinical Trials## B Randomized Evaluation of the Effect of Thrombus Aspiration by Two Different Thrombectomy Devices on Myocardial Blush During Primary Percutaneous Coronary Intervention## B Coronary sinus Percutaneous Mitral Valve Annuloplasty for Ischemic Mitral Regurgitation: First in Man Experience With a Temporary Implant## B Coronary vessels Preclinical Safety Evaluation of a Novel Helical Rotational Thrombectomy Device## B Creatine kinase Diabetes mellitus Drug-Eluting Stents in Patients With Diabetes Mellitus: A Meta-Analysis of Randomized Trials## B The Importance of Fundoscopy for the Interventional Cardiologist## B Diagnostic techniques Morphologic Feature and Frequency of Coronary Pre- Rupture Thin-Cap Fibroatheroma in Patients With Acute Myocardial Infarction and Stable Angina Pectoris: A Three-Vessel Optical Coherence Tomography Study## B The Plaque Destabilization of Nonculprit Lesion in Acute Myocardial Infarction: An Optical Coherence Tomography Study## B Dose-response relationship, drug Effects of Aspirin Dose on Ischemic Events and Bleeding After Percutaneous Coronary Intervention: Insights From the PCI-CURE Study## B Drug therapy Echocardiography, transthoracic Three-Year Clinical and Echocardiographic Follow-Up After Percutaneous Edwards Aortic Valve Implantation for Severe Aortic Stenosis in Compassionate Patients## B Electrocardiography Emergency care Coronary Artery Perforations: Incidence, Predictors and Clinical Outcomes: Multicenter Registry in Japan## B Endothelial function Enzymes Follow-up studies Drug-Eluting Stents for the Treatment of Left Main Coronary Arteries: A Comparison of Serial Angiographic Follow-Up With Sirolimus, Paclitaxel, Zotarolimus, and Tacrolimus-Eluting Stent: Multicenter Registry in Asia## B Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients With Sirolimus-Eluting Stent Failure: Multicenter Registry in Asia## B Long-Term Durability of Endoluminal Stenting for Obstructive Lesions of the Subclavian Artery: Multicenter Registry in Japan## B Gender Referrals in Acute Coronary Events for Cardiac Catheterization, the RACE CAR Study: What Factors Account for Gender Differences in Cardiac Catheterization Referral Rates?## B Gene expression Polymorphisms of Interleukin-1 Genes and Neointimal Proliferation After Percutaneous Coronary Intervention## B Genetics Polymorphisms of Interleukin-1 Genes and Neointimal Proliferation After Percutaneous Coronary Intervention## B Heart catheterization Effect on Long-Term Survival of Hematocrit Drop After Cardiac Catheterization: The Dartmouth Dynamic Registry## B Predictors of Major Vascular Complications in Patients Undergoing Percutaneous Coronary Intervention: Insights From the REPLACE-2 Trial## B The Radial Approach to Percutaneous Coronary Intervention Is Associated With a Lower Risk for Complications Regardless of Radial Procedure Volume: A Report From the American College of Cardiology- National Cardiovascular Data Registry## B Heart failure Depression Worsens Survival and Major Outcomes in Elderly Patients With Chronic Heart Failure: An Analysis of 18,623 Patients in a Community Setting## B Heart failure, treatment An Atrial Decompression Device: Potential Therapy for Congestive Heart Failure## B Heart valve prosthesis An Atrial Decompression Device: Potential Therapy for Congestive Heart Failure## B Image processing, computer-assisted New Technology of Three-Dimensional Coronary Bifurcation Imaging## B Infarct size Insulin Intravascular ultrasound/doppler Characterization of the Intravascular Ultrasound Radiofrequency Signal Within Regions of Acoustic Shadowing Behind Calcium## B Clinical Correlates of Restenosis Following Coronary Implantation of Drug-Eluting Stents## B Coronary Plaque Composition and Creatine Kinase-MB Fraction Enzyme Level After Percutaneous Coronary Stenting: A Virtual Histology Intravascular Ultrasound Analysis## B Impact of Renal Function on Coronary Plaque Characteristics in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Analysis## B Intravascular Ultrasound Assessment of Impaired Myocardial Perfusion After Stent Implantation in Patients With ST- Segment Elevation Myocardial Infarction## B Investigational devices An Atrial Decompression Device: Potential Therapy for Congestive Heart Failure## B Nonpolymer Elution of Biolimus From a Stent Inhibits Intimal Hyperplasia in a Porcine Model## B Preclinical Safety Evaluation of a Novel Helical Rotational Thrombectomy Device## B

4 JACC March 6, 2007 Innovation in Intervention: i2 Summit Subject Index 57B Safety and Efficacy of a New Guidewire for Crossing Chronic Total Occlusions: First in Man Results## B SPIRIT II Study: A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de Novo Native Coronary Artery Lesions## B Stent Strut Apposition of Cypher Select and Taxus Liberte: A Prospective Optical Coherence Tomography Study## B The QuantumCor Device for Mitral Regurgitation: A Radiofrequency Alternative to an Annular Ring## B Ischemia Ischemia, preconditioning A Comparison of Short-and Long-Term Outcomes of Coronary Artery Disease Patients Treated With Bare Metal Stents or Bypass Surgery## B Ischemia, reperfusion A Comparison of Short-and Long-Term Outcomes of Coronary Artery Disease Patients Treated With Bare Metal Stents or Bypass Surgery## B Association of Antiplatelet and Antithrombin Therapy With Ischemia on Holter Monitoring Following Percutaneous Coronary Intervention: A PROTECT TIMI 30 Analysis## B Kidney Clinical Outcomes in Chronic Hemodialysis Patients: Initial and 1-Year Follow-Up Results of the J-Cypher Registry## B Lipid modifying agents Statin Pretreatment Prevents Contrast-Induced Nephropathy and Improves Long-Term Outcome in Patients Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-RENAL Study## B Longitudinal studies Effect on Long-Term Survival of Hematocrit Drop After Cardiac Catheterization: The Dartmouth Dynamic Registry## B Macrophages Circulating Pregnancy-Associated Plasma Protein-A Levels and Long-Term Prognosis in Patients With Chronic Stable Angina Pectoris## B Magnetic resonance imaging One-Year Follow-Up of Left Ventricular Function and Remodeling After Intracoronary Infusion of Bone Marrow-Derived Progenitor Cells After Acute ST- Elevation Myocardial Infarction: Magnetic Resonance Imaging Substudy of the Double-Blind, Randomized, Placebo-Controlled Multicenter REPAIR-AMI Trial## B Metabolic syndrome Mitral regurgitation Percutaneous Mitral Valve Annuloplasty for Ischemic Mitral Regurgitation: First in Man Experience With a Temporary Implant## B The QuantumCor Device for Mitral Regurgitation: A Radiofrequency Alternative to an Annular Ring## B Myocardial infarction, pathophysiology The Plaque Destabilization of Nonculprit Lesion in Acute Myocardial Infarction: An Optical Coherence Tomography Study## B Myocardial infarction, treatment Can Rosuvastatin Administration Before Percutaneous Coronary Intervention Reduce the Periprocedural Myocardial Injury in Patients With Stable Angina? Results of a Randomized Study## B Direct Stenting Is an Independent Predictor of 30-Day Survival in Unselected Patients Admitted for Acute Myocardial Infarction## B Impact of Glomerular Filtration Rate on the Outcomes of Primary Percutaneous Coronary Intervention in ST- Elevation Myocardial Infarction## B Impact of Multivessel Disease on Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock Treated With Percutaneous Coronary Intervention## B Intravascular Ultrasound Assessment of Impaired Myocardial Perfusion After Stent Implantation in Patients With ST- Segment Elevation Myocardial Infarction## B One-Year Follow-Up of Left Ventricular Function and Remodeling After Intracoronary Infusion of Bone Marrow-Derived Progenitor Cells After Acute ST- Elevation Myocardial Infarction: Magnetic Resonance Imaging Substudy of the Double-Blind, Randomized, Placebo-Controlled Multicenter REPAIR-AMI Trial## B One-Year Results of Combined Embolic Protection and Thrombectomy in Percutaneous Coronary Intervention of Acute Myocardial Infarction Using the Proxis - Device## B Quality Improvement: Reducing Door-to-Balloon Times in Patients With ST Elevation Myocardial Infarction: The Penn State HVI Heart Alert Program## B Radial Versus Femoral Arterial Access in Emergent Coronary Interventions for Acute Myocardial Infarction With ST- Segment Elevation## B Randomized Evaluation of the Effect of Thrombus Aspiration by Two Different Thrombectomy Devices on Myocardial Blush During Primary Percutaneous Coronary Intervention## B Time Delay to Rescue Percutaneous Coronary Intervention and Clinical Endpoints: Results From the REACT Study## B Myocardium Outcomes assessment Are Drug-Eluting Stents Superior to Bare Metal Stents in Large Coronary Arteries?## B Comparison of Sirolimus-Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: Two-Year Results From the REWARDS Registry## B Depression Worsens Survival and Major Outcomes in Elderly Patients With Chronic Heart Failure: An Analysis of 18,623 Patients in a Community Setting## B Effect on Long-Term Survival of Hematocrit Drop After Cardiac Catheterization: The Dartmouth Dynamic Registry## B Impact of Combination of Glycoprotein IIb/IIIa Inhibition and Bivalirudin on Long-Term Outcomes Following Percutaneous Coronary Intervention in Real-World Clinical Practice## B Short- and Long-Term Outcomes After Stent-Assisted Percutaneous Treatment of Saphenous Vein Grafts With Drug-Eluting Stents: Have We Made Any Progress?## B Stent Thrombosis in the Modern Drug-Eluting Stent Era Compared to the Bare-Metal Stent Era: A Comparison From a Large Clinical Registry## B Trends in Outcomes Following Percutaneous Coronary Intervention for Chronic Total Occlusions: 25-Year Experience From the Mayo Clinic## B Troponin Elevation After Percutaneous Coronary Intervention Predicts Major Cardiac Adverse Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes: Results From the SYNERGY Trial## B What Is the Optimal Definition of Renal Failure After Percutaneous Coronary Intervention? Findings From the Guthrie Percutaneous Coronary Intervention Registry## B Patent foramen ovale Successful Thermal Coaptation of Patent Foramen Ovale: First Experience and Temporal Histopathologic Healing in a Porcine Model## B Pathology Multiple Thin-Cap Fibroatheromas Assessed by Three-Vessel Histological and Optical Coherence Tomographic Study## B Pathologic Findings of Coronary Bifurcation Stenting - Drug- Eluting Stents Versus Bare Metal Stents## B Successful Thermal Coaptation of Patent Foramen Ovale: First Experience and Temporal Histopathologic Healing in a Porcine Model## B Patterns of care in population Intermediate Volume Operators Attempt Percutaneous Coronary Intervention of Chronic Total Occlusions More Frequently Than Low-or High-Volume Operators: An Analysis From the American College of Cardiology- National Cardiovascular Data Registry Database of 45,826 CTO Patients## B Percutaneous valve repair/replacement Percutaneous Mitral Valve Annuloplasty for Ischemic Mitral Regurgitation: First in Man Experience With a Temporary Implant## B The QuantumCor Device for Mitral Regurgitation: A Radiofrequency Alternative to an Annular Ring## B Three-Year Clinical and Echocardiographic Follow-Up After Percutaneous Edwards Aortic Valve Implantation for Severe Aortic Stenosis in Compassionate Patients## B Peripheral vasculature Long-Term Durability of Endoluminal Stenting for Obstructive Lesions of the Subclavian Artery: Multicenter Registry in Japan## B Morphology of the Stent Fracture Influences the Outcome Following Superficial Femoral Artery Stenting## B

5 58B Subject Index - Innovation in Intervention: i2 Summit 2007J jacc March 6, 2007 Pharmacology Prevalence of Aspirin and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention: Comparison of Triple Versus Dual Antiplatelet Therapy## B Physiology Physiologic Evaluation of Myocardial Bridging: A New Analysis for an Old Disease## B Plaque Coronary Plaque Composition and Creatine Kinase-MB Fraction Enzyme Level After Percutaneous Coronary Stenting: A Virtual Histology Intravascular Ultrasound Analysis## B Quantitative Analysis of Vulnerable Plaque Color Using LCH Color Space## B The Plaque Destabilization of Nonculprit Lesion in Acute Myocardial Infarction: An Optical Coherence Tomography Study## B Platelet inhibitors Association of Antiplatelet and Antithrombin Therapy With Ischemia on Holter Monitoring Following Percutaneous Coronary Intervention: A PROTECT TIMI 30 Analysis## B Post-Coronary Intervention Recurrent Ischemia in the Presence of Adequate Platelet Inhibition by Dual Antiplatelet Therapy: What Are We Overlooking?## B Prevalence of Aspirin and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention: Comparison of Triple Versus Dual Antiplatelet Therapy## B Three-Year Outcome of Intracoronary Stand-Alone Bolus Administration of Eptifibatide During Coronary Intervention##915- Platelets Platelet Activation and Deposition Patterns After Exposure to the Surface of Paclitaxel-Eluting Stents: An In Vitro Flow Chamber Study## B Prevention Prognosis Are Paclitaxel-Eluting Stents Safe and Effective Compared to Bare Metal Stents? Long-Term Results From the TAXUS Meta-Analysis## B Circulating Pregnancy-Associated Plasma Protein-A Levels and Long-Term Prognosis in Patients With Chronic Stable Angina Pectoris## B Public policy Depression Worsens Survival and Major Outcomes in Elderly Patients With Chronic Heart Failure: An Analysis of 18,623 Patients in a Community Setting## B Quality performance measurement and improvement Radiation Efficacy and Safety of Absorbable Metallic Stents With Adjunct Intracoronary Beta Radiation in Porcine Coronary Arteries## B Eliminating Unnecessary X-Ray Exposure During Interventional Procedures: Role of Automatic Fluoroscopy Lockout## B Radiation Exposure During Flat Detector Fluoroscopy: Recognition of a Unique Hazard to Obese Patients## B Safety and Efficacy of Carotid Artery Stenting in Patients With a History of Neck Irradiation## B X-Ray Dose-Awareness in the Interventional Laboratory: Interactive Display Improves Safety## B Renal circulation Renal Frame Count Can Identify the Good Responder of Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis Which Induced Renal Dysfunction## B Renal function Clinical Outcomes in Chronic Hemodialysis Patients: Initial and 1-Year Follow-Up Results of the J-Cypher Registry## B Impact of Glomerular Filtration Rate on the Outcomes of Primary Percutaneous Coronary Intervention in ST- Elevation Myocardial Infarction## B Impact of Renal Function on Coronary Plaque Characteristics in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Analysis## B Impact of Renal Insufficiency on Clinical Outcomes Following Drug-Eluting Stent Implantation## B Outcomes of Bivalirudin in Moderate-and High-Risk Patients With Acute Coronary Syndromes and Renal Insufficiency: An ACUITY Substudy## B Renal Frame Count Can Identify the Good Responder of Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis Which Induced Renal Dysfunction## B Statin Pretreatment Prevents Contrast-Induced Nephropathy and Improves Long-Term Outcome in Patients Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-RENAL Study## B The Effect of Contrast-Induced Nephropathy on Long-Term Renal Function## B The Incidence of Contrast-Induced Nephropathy With Iomeprol Is Similar to the Incidence of Contrast-Induced Nephropathy With Iopamidol## B What Is the Optimal Definition of Renal Failure After Percutaneous Coronary Intervention? Findings From the Guthrie Percutaneous Coronary Intervention Registry## B Reperfusion Restenosis Are Angiographic Restenosis Criteria Functionally Relevant in Evaluation of Jailed Side Branch Lesions at Follow-Up Angiograms?## B Clinical Correlates of Restenosis Following Coronary Implantation of Drug-Eluting Stents## B Detection of In-Stent Restenosis by 64-Detector Computed Tomographic Coronary Angiography: Comparison With Quantitative Selective Coronary Angiography## B Drug-Eluting Stents Are No Better Than Bare Metal in Vein Grafts: Results From the Strategic Transcatheter Evaluation of New Therapies Group## B Drug-Eluting Stents for the Treatment of Left Main Coronary Arteries: A Comparison of Serial Angiographic Follow-Up With Sirolimus, Paclitaxel, Zotarolimus, and Tacrolimus-Eluting Stent: Multicenter Registry in Asia## B Drug-Eluting Stents in the Treatment of Saphenous Vein Graft Disease: Poor Outcome in Diffusely Diseased Grafts## B Efficacy and Safety of Absorbable Metallic Stents With Adjunct Intracoronary Beta Radiation in Porcine Coronary Arteries## B Efficacy and Safety of Pimecrolimus-Eluting Stents in Porcine Coronary Arteries## B First Real-World Experience and 6-Month Clinical Outcome in Patients Treated With a Genous TM Endothelial Progenitor Cell Capturing Stent## B Illicit Drug Use Is an Independent Risk Factor for Coronary In-Stent Restenosis## B Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients With Sirolimus-Eluting Stent Failure: Multicenter Registry in Asia## B Intravascular Delivery of Sirolimus With Two Biodegradable Polymers Using Novel Electro-Grafting Technology## B Long-Term 1-Year Follow-Up After Treatment of Drug-Eluting Stent Restenosis With Repeat DES: To SWITCH or Not to SWITCH?## B Nonpolymer Elution of Biolimus From a Stent Inhibits Intimal Hyperplasia in a Porcine Model## B Paclitaxel-Eluting Stents for In-Stent Restenosis of Sirolimus- Eluting Stents: 12-Month Outcomes## B Polymorphisms of Interleukin-1 Genes and Neointimal Proliferation After Percutaneous Coronary Intervention## B Predictors for Diffuse In-Stent Restenosis After Taxus Sent Implantation: Analysis From The Taxus IV and V Trials## B Relationship Between the 3D Structure of the Left Main Coronary Artery Bifurcation and Double Stenting## B Rotational Atherectomy Prior to the Stenting With Sirolimus- Eluting Stent for Diffuse In-Stent Restenosis: Multicenter Registry in Asia## B Stent Thrombosis in the Modern Drug-Eluting Stent Era Compared to the Bare-Metal Stent Era: A Comparison From a Large Clinical Registry## B The Difference of the Late Restenosis Between Sirolimus- Eluting Stents and Bare-Metal Stents: The Difference in Site, Type and Time Course Pattern of the Late Restenosis## B The Importance of Fundoscopy for the Interventional Cardiologist## B Treatment of Side Branch Plaque Shift in Coronary Bifurcation Lesions With Balloon Cryoangioplasty## B Revascularization

6 JACC March 6, 2007 Innovation in Intervention: i2 Summit Subject Index 59B Bivalirudin and Heparin Plus Glycoprotein Inhibition Results in Similar Mortality and Ischemic Outcomes in Patients Undergoing Percutaneous Coronary Intervention: The DEScover Registry## B Despite Safety and Benefit, Distal Embolic Protection Is Underutilized in Saphenous Vein Graft Percutaneous Intervention: An Analysis of 19,562 Patients From the American College of Cardiology-National Cardiovascular Data Registry## B One-Year Results of Combined Embolic Protection and Thrombectomy in Percutaneous Coronary Intervention of Acute Myocardial Infarction Using the Proxis - Device## B Predictors of Major Vascular Complications in Patients Undergoing Percutaneous Coronary Intervention: Insights From the REPLACE-2 Trial## B Safety and Efficacy of Carotid Artery Stenting in Patients With a History of Neck Irradiation## B Three-Year Outcome of Intracoronary Stand-Alone Bolus Administration of Eptifibatide During Coronary Intervention##915- Treatment of Side Branch Plaque Shift in Coronary Bifurcation Lesions With Balloon Cryoangioplasty## B Risk factors Comparison of Mid-Term Results of Left Main Disease Treatment by Risk Stratification Systems## B Illicit Drug Use Is an Independent Risk Factor for Coronary In-Stent Restenosis## B Incidence of Late Angiographic Stent Thrombosis of Sirolimus-Eluting Stents## B Octogenarian Status Is an Independent Risk Factor for Adverse Outcomes After Carotid Stenting## B Risk factors, gender-related Risk prediction Impact of Multivessel Disease on Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock Treated With Percutaneous Coronary Intervention## B Referrals in Acute Coronary Events for Cardiac Catheterization, the RACE CAR Study: What Factors Account for Gender Differences in Cardiac Catheterization Referral Rates?## B Shock Spectrum analysis ST segments Intravascular Ultrasound Assessment of Impaired Myocardial Perfusion After Stent Implantation in Patients With ST- Segment Elevation Myocardial Infarction## B Stent A Prospective Multicenter Randomized Comparison of Paclitaxel Versus Sirolimus-Eluting Stents for Long Coronary Lesion: Six--Month Angiographic Follow-Up Study: Impact of Cilostazol on Neointimal Hyperplasia## B Angiographic and Clinical Outcomes Among 1,317 Patients Treated With the Endeavor Zotarolimus-Eluting Stent for Native Coronary Artery Disease: Two-Year High-Risk Subgroup Analysis## B Are Drug-Eluting Stents Superior to Bare Metal Stents in Large Coronary Arteries?## B Are Paclitaxel-Eluting Stents Safe and Effective Compared to Bare Metal Stents? Long-Term Results From the TAXUS Meta-Analysis## B Are Patients With Drug Eluting Stents at Increased Risk for Late Stent Thrombosis? Results From a Nested-Case- Control Study## B Bifurcation Lesion Intervention With Cypher and Endeavor Drug-Eluting Stents: A Comparison## B Can Rosuvastatin Administration Before Percutaneous Coronary Intervention Reduce the Periprocedural Myocardial Injury in Patients With Stable Angina? Results of a Randomized Study## B Clinical Correlates of Restenosis Following Coronary Implantation of Drug-Eluting Stents## B Comparison of Mid-Term Results of Left Main Disease Treatment by Risk Stratification Systems## B Coronary Plaque Composition and Creatine Kinase-MB Fraction Enzyme Level After Percutaneous Coronary Stenting: A Virtual Histology Intravascular Ultrasound Analysis## B Coronary Stent Assessibility by 64-Slice Multi-Detector Computed Tomography## B Culotte Versus T-Stenting in Bifurcation Lesions: Immediate Clinical and Angiographic Results and Mid-Term Clinical Follow-Up## B Detection of In-Stent Restenosis by 64-Detector Computed Tomographic Coronary Angiography: Comparison With Quantitative Selective Coronary Angiography## B Differential Predictors for Subacute, Late and Very Late Drug- Eluting Stent Thrombosis: Results From the Multicenter ESTROFA Study## B Direct Stenting Is an Independent Predictor of 30-Day Survival in Unselected Patients Admitted for Acute Myocardial Infarction## B Drug-Eluting Stents Are No Better Than Bare Metal in Vein Grafts: Results From the Strategic Transcatheter Evaluation of New Therapies Group## B Drug-Eluting Stents for the Treatment of Left Main Coronary Arteries: A Comparison of Serial Angiographic Follow-Up With Sirolimus, Paclitaxel, Zotarolimus, and Tacrolimus-Eluting Stent: Multicenter Registry in Asia## B Drug-Eluting Stents in Patients With Diabetes Mellitus: A Meta-Analysis of Randomized Trials## B Drug-Eluting Stents in the Treatment of Saphenous Vein Graft Disease: Poor Outcome in Diffusely Diseased Grafts## B Efficacy and Safety of Absorbable Metallic Stents With Adjunct Intracoronary Beta Radiation in Porcine Coronary Arteries## B Efficacy and Safety of Pimecrolimus-Eluting Stents in Porcine Coronary Arteries## B Favorable One-Year Outcome Following Drug-Eluting Stent Implantation in Non-Bifurcational Lesions Involving Unprotected Left Main Coronary Artery: A Multicenter Registry## B First Real-World Experience and 6-Month Clinical Outcome in Patients Treated With a Genous TM Endothelial Progenitor Cell Capturing Stent## B Impact of Combination of Glycoprotein IIb/IIIa Inhibition and Bivalirudin on Long-Term Outcomes Following Percutaneous Coronary Intervention in Real-World Clinical Practice## B Impact of Glomerular Filtration Rate on the Outcomes of Primary Percutaneous Coronary Intervention in ST- Elevation Myocardial Infarction## B Impact of Renal Insufficiency on Clinical Outcomes Following Drug-Eluting Stent Implantation## B Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients With Sirolimus-Eluting Stent Failure: Multicenter Registry in Asia## B Incidence of Late Angiographic Stent Thrombosis of Sirolimus-Eluting Stents## B Initial Assessment of a Novel Anti-inflammatory Salicylic Acid-Based Absorbable Polymer for Use in Fully Biodegradable Coronary Stents## B Late Thrombosis in Drug-Eluting Stents: Meta-Analysis of All Published Case Reports.## B Long-Term 1-Year Follow-Up After Treatment of Drug-Eluting Stent Restenosis With Repeat DES: To SWITCH or Not to SWITCH?## B Long-Term Durability of Endoluminal Stenting for Obstructive Lesions of the Subclavian Artery: Multicenter Registry in Japan## B Morphology of the Stent Fracture Influences the Outcome Following Superficial Femoral Artery Stenting## B New Technology of Three-Dimensional Coronary Bifurcation Imaging## B Nonpolymer Elution of Biolimus From a Stent Inhibits Intimal Hyperplasia in a Porcine Model## B Ostial Versus Crossover Stenting With Sirolimus-Eluting Stent for the Treatment of Ostial Left Anterior Descending Artery Lesions## B Paclitaxel-Eluting Stents for In-Stent Restenosis of Sirolimus- Eluting Stents: 12-Month Outcomes## B Pathologic Findings of Coronary Bifurcation Stenting - Drug- Eluting Stents Versus Bare Metal Stents## B Platelet Activation and Deposition Patterns After Exposure to the Surface of Paclitaxel-Eluting Stents: An In Vitro Flow Chamber Study## B Predictors for Diffuse In-Stent Restenosis After Taxus Sent Implantation: Analysis From The Taxus IV and V Trials## B Predictors of Irreversible Events After Percutaneous Coronary Intervention in Unprotected Left Main Lesions## B Prevalence of Aspirin and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention: Comparison of Triple Versus Dual Antiplatelet Therapy## B Relationship Between the 3D Structure of the Left Main Coronary Artery Bifurcation and Double Stenting## B Renal Frame Count Can Identify the Good Responder of Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis Which Induced Renal Dysfunction## B Rotational Atherectomy Prior to the Stenting With Sirolimus- Eluting Stent for Diffuse In-Stent Restenosis: Multicenter Registry in Asia## B Safety and Efficacy of Desensitization Procedure in Patients With Aspirin Sensitivity Undergoing Percutaneous Coronary Stenting## B Short- and Long-Term Outcomes After Stent-Assisted Percutaneous Treatment of Saphenous Vein Grafts With Drug-Eluting Stents: Have We Made Any Progress?## B SPIRIT II Study: A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de Novo Native Coronary Artery Lesions## B Stent Strut Apposition of Cypher Select and Taxus Liberte: A Prospective Optical Coherence Tomography Study## B Stent Thrombosis in the Modern Drug-Eluting Stent Era Compared to the Bare-Metal Stent Era: A Comparison From a Large Clinical Registry## B The Clinical Characteristics of Early Versus Late Stent Thrombosis: A Multicenter Analysis## B

7 60B Subject Index - Innovation in Intervention: i2 Summit 2007J jacc March 6, 2007 The Difference of the Late Restenosis Between Sirolimus- Eluting Stents and Bare-Metal Stents: The Difference in Site, Type and Time Course Pattern of the Late Restenosis## B The Efficacy of Pre-Drug-Eluting Stent Debulking by Directional Atherectomy for Bifurcated Lesions: A Multicenter Prospective Registry## B The Endeavor V Registry: Real-World 12-Month Safety and Efficacy Data for the Endeavor Zotarolimus-Eluting Stent## B The Importance of Fundoscopy for the Interventional Cardiologist## B Two-Year Outcomes From the ENDEAVOR III Trial: A Randomized Trial of the Endeavor Zotarolimus-Eluting Stent Compared With the Cypher Sirolimus-Eluting Stent## B What Kind of Polymer Is Better for Bifurcation Stenting?## B Stroke Efficacy and Safety of Carotid Artery Stenting in Patients Scheduled for Cardiac Surgery## B Feasibility and Safety of Drug-Eluting Stent Implantaton in the Treatment of Stenosis of Vertebrobasilar Arteries## B Octogenarian Status Is an Independent Risk Factor for Adverse Outcomes After Carotid Stenting## B Tech assessment Eliminating Unnecessary X-Ray Exposure During Interventional Procedures: Role of Automatic Fluoroscopy Lockout## B Radiation Exposure During Flat Detector Fluoroscopy: Recognition of a Unique Hazard to Obese Patients## B X-Ray Dose-Awareness in the Interventional Laboratory: Interactive Display Improves Safety## B Thrombin inhibitors Association of Antiplatelet and Antithrombin Therapy With Ischemia on Holter Monitoring Following Percutaneous Coronary Intervention: A PROTECT TIMI 30 Analysis## B Thrombolysis Thrombosis Angiographic Presentation of Stent Thrombosis in the Drug- Eluting Stent Era## B Are Patients With Drug Eluting Stents at Increased Risk for Late Stent Thrombosis? Results From a Nested-Case- Control Study## B Comparison of Sirolimus-Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: Two-Year Results From the REWARDS Registry## B Differential Predictors for Subacute, Late and Very Late Drug- Eluting Stent Thrombosis: Results From the Multicenter ESTROFA Study## B Impact of Techniques to Reduce or Prevent Distal Embolization During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Meta- Analysis of Randomized Clinical Trials## B Late Thrombosis in Drug-Eluting Stents: Meta-Analysis of All Published Case Reports.## B Platelet Activation and Deposition Patterns After Exposure to the Surface of Paclitaxel-Eluting Stents: An In Vitro Flow Chamber Study## B Preclinical Safety Evaluation of a Novel Helical Rotational Thrombectomy Device## B Safety and Efficacy of Desensitization Procedure in Patients With Aspirin Sensitivity Undergoing Percutaneous Coronary Stenting## B Stent Strut Apposition of Cypher Select and Taxus Liberte: A Prospective Optical Coherence Tomography Study## B The Clinical Characteristics of Early Versus Late Stent Thrombosis: A Multicenter Analysis## B Tomography Detection of In-Stent Restenosis by 64-Detector Computed Tomographic Coronary Angiography: Comparison With Quantitative Selective Coronary Angiography## B Transplantation Initial Clinical Experience With Right Ventricular Endocardial Thermography in Transplanted and Coronary Artery Disease Patients.## B Troponin Troponin Elevation After Percutaneous Coronary Intervention Predicts Major Cardiac Adverse Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes: Results From the SYNERGY Trial## B Ultrasonic diagnosis Unstable angina A Prospective, Randomized Trial of Bivalirudin in Acute Coronary Syndromes: One Year Results From the ACUITY Trial## B Valvular disease Experience With the Self-Expanding 21 French Percutaneous CoreValve Aortic Valve Prosthesis in High-Risk and Inoperable Patients With Symptomatic Aortic Valve Stenosis## B Periventricular Nonsurgical Aortic Valve Placement With Subsequent Use of Myocardial Plugs## B Vascular surgery Can Inflammatory Markers Predict Major Adverse Cardiac Events in Patients Undergoing Noncardiac Vascular Surgery?## B Ventricular remodeling